Label & Dose IVS: Financial statements 2018
CVR: 38204874
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Label & Dose IVS (CVR 38204874) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 19,018 and a net result of DKK 17,468. Equity in the 2018 report amounted to DKK 813. The solvency ratio was 1.7%.
- Gross Profit
- DKK 19,018
- Profit/Loss
- DKK 17,468
- Equity
- DKK 813
- Total Assets
- DKK 46,547
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of November 28, 2018, Jakob Mikkel Bo Dyhr Hansen has stepped down as director of Label & Dose IVS.
As of November 28, 2018, Morten Lund Nielsen has stepped down as director of Label & Dose IVS.
Label & Dose IVS has published its interim report for the period November 23, 2016 – December 31, 2017.
About Label & Dose IVS
Label & Dose IVS was a Danish company of the type Iværksætterselskab based in København Ø, founded in 2016. The company has been dissolved on 29 October 2021. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. According to the 2020 annual report, the company had an average of 0 employees. In 2020, the company reported a gross profit of DKK -5,625 and a net result of DKK -3,103 compared with DKK -41,160 the year before. Equity in the 2020 report amounted to DKK -43,450.